Genetic Polymorphisms in Sepsis

Critical Care Nursing Clinics of North America

Volumn 23, Issue 1, 2011, Pages 181-202

  Namath, Allen ^a   Patterson, Andrew J ^b  

^a SANTA CLARA VALLEY MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Gene; Genetic variation; Polymorphism; Predisposition; Sepsis

Indexed keywords

GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HUMAN; REVIEW; SEPSIS;

GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, GENETIC; SEPSIS;

EID: 79751502811     PISSN: 08995885     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccell.2010.12.011     Document Type: Review

References (95)

1. Sutherland A.M., Walley K.R., Russell J.A. Polymorphisms in CD14, mannose-binding lectin, and Toll-like receptor-2 are associated with increased prevalence of infection in critically ill adults. Crit Care Med 2005, 33(3):638-644.
2. Henckaerts L., Nielsen K.R., Steffensen R., et al. Polymorphisms in innate immunity genes predispose to bacteremia and death in the medical intensive care unit. Crit Care Med 2009, 37(1):192-201. e191-3.
3. Sørensen T., Nielsen G., Andersen P., et al. Genetic and environmental influences on premature death in adult adoptees. N Engl J Med 1988, 318(12):727-732.
4. Burgner D., Jamieson S.E., Blackwell J.M. Genetic susceptibility to infectious diseases: big is beautiful, but will bigger be even better?. Lancet Infect Dis 2006, 6(10):653-663.
5. Albright F.S., Orlando P., Pavia A.T., et al. Evidence for a heritable predisposition to death due to influenza. J Infect Dis 2008, 197(1):18-24.
6. Barber R.C., Chang L.Y., Arnoldo B.D., et al. Innate immunity SNPs are associated with risk for severe sepsis after burn injury. Clin Med Res 2006, 4(4):250-255.
7. Kayser M., Liu F., Janssens A.C., et al. Three genome-wide association studies and a linkage analysis identify HERC2 as a human iris color gene. Am J Hum Genet 2008, 82(2):411-423.
8. Soranzo N., Rivadeneira F., Chinappen-Horsley U., et al. Meta-analysis of genome-wide scans for human adult stature identifies novel Loci and associations with measures of skeletal frame size. PLoS Genet 2009, 5(4):e1000445.
9. Torkamani A., Topol E.J., Schork N.J. Pathway analysis of seven common diseases assessed by genome-wide association. Genomics 2008, 92(5):265-272.
10. Available at: Accessed May 15, 2009. http://wtccc.org.uk.
11. Arcaroli J., Silva E., Maloney J.P., et al. Variant IRAK-1 haplotype is associated with increased nuclear factor-kappaB activation and worse outcomes in sepsis. Am J Respir Crit Care Med 2006, 173(12):1335-1341.
12. Chen Q.X., Wu S.J., Wang H.H., et al. Protein C -1641A/-1654C haplotype is associated with organ dysfunction and the fatal outcome of severe sepsis in Chinese Han population. Hum Genet 2008, 123(3):281-287.
13. Mlekusch W., Exner M., Schillinger M., et al. E-Selectin and restenosis after femoropopliteal angioplasty: prognostic impact of the Ser128Arg genotype and plasma levels. Thromb Haemost 2004, 91(1):171-179.
14. Jilma B., Marsik C., Kovar F., et al. The single nucleotide polymorphism Ser128Arg in the E-selectin gene is associated with enhanced coagulation during human endotoxemia. Blood 2005, 105(6):2380-2383.
15. Grocott H.P., Newman M.F., El-Moalem H., et al. Apolipoprotein E genotype differentially influences the proinflammatory and anti-inflammatory response to cardiopulmonary bypass. J Thorac Cardiovasc Surg 2001, 122(3):622-623.
16. Lynch J.R., Tang W., Wang H., et al. APOE genotype and an ApoE-mimetic peptide modify the systemic and central nervous system inflammatory response. J Biol Chem 2003, 278(49):48529-48533.
17. Wang H., Christensen D.J., Vitek M.P., et al. APOE genotype affects outcome in a murine model of sepsis: implications for a new treatment strategy. Anaesth Intensive Care 2009, 37(1):38-45.
18. Jones J., Chen L.S., Baudhuin L., et al. Relationships between C-reactive protein concentration and genotype in healthy volunteers. Clin Chem Lab Med 2009, 47(1):20-25.
19. Eklund C., Huttunen R., Syrjanen J., et al. Polymorphism of the C-reactive protein gene is associated with mortality in bacteraemia. Scand J Infect Dis 2006, 38(11/12):1069-1073.
20. Saleh M., Vaillancourt J.P., Graham R.K., et al. Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms. Nature 2004, 429(6987):75-79.
21. Baier R.J., Loggins J., Yanamandra K. IL-10, IL-6 and CD14 polymorphisms and sepsis outcome in ventilated very low birth weight infants. BMC Med 2006, 4:10.
22. de Aguiar B.B., Girardi I., Paskulin D.D., et al. CD14 expression in the first 24h of sepsis: effect of -260C>T CD14 SNP. Immunol Invest 2008, 37(8):752-769.
23. D'Avila L.C., Albarus M.H., Franco C.R., et al. Effect of CD14-260C>T polymorphism on the mortality of critically ill patients. Immunol Cell Biol 2006, 84(4):342-348.
24. Marsik C., Sunder-Plassmann R., Jilma B., et al. The C-reactive protein (+)1444C/T alteration modulates the inflammation and coagulation response in human endotoxemia. Clin Chem 2006, 52(10):1952-1957.
25. Flores C., Maca-Meyer N., Perez-Mendez L., et al. A CXCL2 tandem repeat promoter polymorphism is associated with susceptibility to severe sepsis in the Spanish population. Genes Immun 2006, 7(2):141-149.
26. Villar J., Perez-Mendez L., Flores C., et al. A CXCL2 polymorphism is associated with better outcomes in patients with severe sepsis. Crit Care Med 2007, 35(10):2292-2297.
27. O'Dwyer M.J., Dempsey F., Crowley V., et al. Septic shock is correlated with asymmetrical dimethyl arginine levels, which may be influenced by a polymorphism in the dimethylarginine dimethylaminohydrolase II gene: a prospective observational study. Crit Care 2006, 10(5):R139.
28. Chen Q.X., Lv C., Huang L.X., et al. Genomic variations within DEFB1 are associated with the susceptibility to and the fatal outcome of severe sepsis in Chinese Han population. Genes Immun 2007, 8(5):439-443.
29. Sipahi T., Pocan H., Akar N. Effect of various genetic polymorphisms on the incidence and outcome of severe sepsis. Clin Appl Thromb Hemost 2006, 12(1):47-54.
30. Kerlin B.A., Yan S.B., Isermann B.H., et al. Survival advantage associated with heterozygous factor V Leiden mutation in patients with severe sepsis and in mouse endotoxemia. Blood 2003, 102(9):3085-3092.
31. Kovar F.M., Marsik C., Jilma B., et al. The fibrinogen -148 C/T polymorphism influences inflammatory response in experimental endotoxemia in vivo. Thromb Res 2007, 120(5):727-731.
32. Manocha S., Russell J.A., Sutherland A.M., et al. Fibrinogen-beta gene haplotype is associated with mortality in sepsis. J Infect 2007, 54(6):572-577.
33. Kee C., Cheong K.Y., Pham K., et al. Genetic variation in heat shock protein 70 is associated with septic shock: narrowing the association to a specific haplotype. Int J Immunogenet 2008, 35(6):465-473.
34. Chapman S.J., Khor C.C., Vannberg F.O., et al. IkappaB genetic polymorphisms and invasive pneumococcal disease. Am J Respir Crit Care Med 2007, 176(2):181-187.
35. Sabelnikovs O., Nikitina-Zake L., Vanags I. Association of IL-6 promoter polymorphism -174C/G with outcome in severe sepsis. Crit Care 2008, 12:462.
36. Sutherland A.M., Walley K.R., Manocha S., et al. The association of interleukin 6 haplotype clades with mortality in critically ill adults. Arch Intern Med 2005, 165(1):75-82.
37. Gu W., Du D.Y., Huang J., et al. Identification of interleukin-6 promoter polymorphisms in the Chinese Han population and their functional significance. Crit Care Med 2008, 36(5):1437-1443.
38. Wattanathum A., Manocha S., Groshaus H., et al. Interleukin-10 haplotype associated with increased mortality in critically ill patients with sepsis from pneumonia but not in patients with extrapulmonary sepsis. Chest 2005, 128(3):1690-1698.
39. Stanilova S.A., Miteva L.D., Karakolev Z.T., et al. Interleukin-10-1082 promoter polymorphism in association with cytokine production and sepsis susceptibility. Intensive Care Med 2006, 32(2):260-266.
40. Gordon A.C., Waheed U., Hansen T.K., et al. Mannose-binding lectin polymorphisms in severe sepsis: relationship to levels, incidence, and outcome. Shock 2006, 25(1):88-93.
41. Smithson A., Munoz A., Suarez B., et al. Association between mannose-binding lectin deficiency and septic shock following acute pyelonephritis due to Escherichia coli. Clin Vaccine Immunol 2007, 14(3):256-261.
42. Yende S., Angus D.C., Kong L., et al. The influence of macrophage migration inhibitory factor gene polymorphisms on outcome from community-acquired pneumonia. FASEB J 2009, 23(8):2403-2411.
43. Temple S.E., Cheong K.Y., Price P., et al. The microsatellite, macrophage migration inhibitory factor -794, may influence gene expression in human mononuclear cells stimulated with E. coli or S. pneumoniae. Int J Immunogenet 2008, 35(4/5):309-316.
44. Gomez R., O'Keeffe T., Chang L.Y., et al. Association of mitochondrial allele 4216C with increased risk for complicated sepsis and death after traumatic injury. J Trauma 2009, 66(3):850-857. [discussion: 857-8].
45. Baudouin S.V., Saunders D., Tiangyou W., et al. Mitochondrial DNA and survival after sepsis: a prospective study. Lancet 2005, 366(9503):2118-2121.
46. Yang Y., Shou Z., Zhang P., et al. Mitochondrial DNA haplogroup R predicts survival advantage in severe sepsis in the Han population. Genet Med 2008, 10(3):187-192.
47. Gao L., Grant A., Halder I., et al. Novel polymorphisms in the myosin light chain kinase gene confer risk for acute lung injury. Am J Respir Cell Mol Biol 2006, 34(4):487-495.
48. Brenmoehl J., Herfarth H., Gluck T., et al. Genetic variants in the NOD2/CARD15 gene are associated with early mortality in sepsis patients. Intensive Care Med 2007, 33(9):1541-1548.
49. Garcia-Segarra G., Espinosa G., Tassies D., et al. Increased mortality in septic shock with the 4G/4G genotype of plasminogen activator inhibitor 1 in patients of white descent. Intensive Care Med 2007, 33(8):1354-1362.
50. Binder A., Endler G., Muller M., et al. 4G4G genotype of the plasminogen activator inhibitor-1 promoter polymorphism associates with disseminated intravascular coagulation in children with systemic meningococcemia. J Thromb Haemost 2007, 5(10):2049-2054.
51. Russell J.A., Wellman H., Walley K.R. Protein C rs2069912 C allele is associated with increased mortality from severe sepsis in North Americans of East Asian ancestry. Hum Genet 2008, 123(6):661-663.
52. Walley K.R., Russell J.A. Protein C -1641 AA is associated with decreased survival and more organ dysfunction in severe sepsis. Crit Care Med 2007, 35(1):12-17.
53. Binder A., Endler G., Rieger S., et al. Protein C promoter polymorphisms associate with sepsis in children with systemic meningococcemia. Hum Genet 2007, 122(2):183-190.
54. Sipahi T., Kuybulu A., Ozturk A., et al. Protein Z G79A polymorphism in patients with severe sepsis. Clin Appl Thromb Hemost 2009, 16(3):334-336.
55. Khor C.C., Chapman S.J., Vannberg F.O., et al. A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis. Nat Genet 2007, 39(4):523-528.
56. Wurfel M.M., Gordon A.C., Holden T.D., et al. Toll-like receptor 1 polymorphisms affect innate immune responses and outcomes in sepsis. Am J Respir Crit Care Med 2008, 178(7):710-720.
57. Shalhub S., Junker C.E., Imahara S.D., et al. Variation in the TLR4 gene influences the risk of organ failure and shock posttrauma: a cohort study. J Trauma 2009, 66(1):115-122. [discussion: 122-3].
58. Van der Graaf C.A., Netea M.G., Morre S.A., et al. Toll-like receptor 4 Asp299Gly/Thr399Ile polymorphisms are a risk factor for Candida bloodstream infection. Eur Cytokine Netw 2006, 17(1):29-34.
59. Yuan F.F., Marks K., Wong M., et al. Clinical relevance of TLR2, TLR4, CD14 and FcgammaRIIA gene polymorphisms in Streptococcus pneumoniae infection. Immunol Cell Biol 2008, 86(3):268-270.
60. Read R.C., Teare D.M., Pridmore A.C., et al. The tumor necrosis factor polymorphism TNF (-308) is associated with susceptibility to meningococcal sepsis, but not with lethality. Crit Care Med 2009, 37(4):1237-1243.
61. Nakada T.A., Hirasawa H., Oda S., et al. Influence of toll-like receptor 4, CD14, tumor necrosis factor, and interleukin-10 gene polymorphisms on clinical outcome in Japanese critically ill patients. J Surg Res 2005, 129(2):322-328.
62. Shalhub S., Pham T.N., Gibran N.S., et al. Tumor necrosis factor gene variation and the risk of mortality after burn injury: a cohort study. J Burn Care Res 2009, 30(1):105-111.
63. Taudorf S., Krabbe K.S., Berg R.M., et al. Common studied polymorphisms do not affect plasma cytokine levels upon endotoxin exposure in humans. Clin Exp Immunol 2008, 152(1):147-152.
64. Azim K., McManus R., Brophy K., et al. Genetic polymorphisms and the risk of infection following esophagectomy. Positive association with TNF-alpha gene -308 genotype. Ann Surg 2007, 246(1):122-128.
65. Kovar F.M., Marsik C., Cvitko T., et al. The tumor necrosis factor alpha -308 G/A polymorphism does not influence inflammation and coagulation response in human endotoxemia. Shock 2007, 27(3):238-241.
66. Schueller A.C., Heep A., Kattner E., et al. Prevalence of two tumor necrosis factor gene polymorphisms in premature infants with early onset sepsis. Biol Neonate 2006, 90(4):229-232.
67. Gordon A.C., Lagan A.L., Aganna E., et al. TNF and TNFR polymorphisms in severe sepsis and septic shock: a prospective multicentre study. Genes Immun 2004, 5(8):631-640.
68. Barber R.C., Aragaki C.C., Rivera-Chavez F.A., et al. TLR4 and TNF-alpha polymorphisms are associated with an increased risk for severe sepsis following burn injury. J Med Genet 2004, 41(11):808-813.
69. Chen Q., Zhou H., Wu S., et al. Lack of association between TREM-1 gene polymorphisms and severe sepsis in a Chinese Han population. Hum Immunol 2008, 69(3):220-226.
70. Available at:, Accessed May 12, 2009. http://www.hapmap.org.
71. Birney E., Stamatoyannopoulos J.A., Dutta A., et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 2007, 447(7146):799-816.
72. Available at: September 9, 2008. Accessed May 6, 2009. http://nihroadmap.nih.gov/GTEx/index.asp.
73. Gibson G., Weir B. The quantitative genetics of transcription. Trends Genet 2005, 21(11):616-623.
74. Schrier R.W., Wang W. Acute renal failure and sepsis. N Engl J Med 2004, 351(2):159-169.
75. Parker M.M., Shelhamer J.H., Bacharach S.L., et al. Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 1984, 100(4):483-490.
76. Geier A., Fickert P., Trauner M. Mechanisms of disease: mechanisms and clinical implications of cholestasis in sepsis. Nat Clin Pract Gastroenterol Hepatol 2006, 3(10):574-585.
77. Available at:, Accessed May 12, 2009. http://www.1000genomes.org.
78. Available at:, Accessed May 17, 2009. http://nihroadmap.nih.gov/hmp.
79. Available at:, Accessed May 21, 2009. http://www.illumina.com.
80. Available at:, Accessed May 20, 2009. http://www.affymetrix.com.
81. Available at:, Accessed May 25, 2009. http://www.fluidigm.com.
82. Available at:, Accessed June 22, 2009. http://www.AppliedBiosystems.com.
83. Korlach J., Marks P.J., Cicero R.L., et al. Selective aluminum passivation for targeted immobilization of single DNA polymerase molecules in zero-mode waveguide nanostructures. Proc Natl Acad Sci U S A 2008, 105(4):1176-1181.
84. Eid J., Fehr A., Gray J., et al. Real-time DNA sequencing from single polymerase molecules. Science 2009, 323(5910):133-138.
85. Clarke J., Wu H., Jayasinghe L., et al. Continuous base identification for single-molecule nanopore DNA sequencing. Nat Nanotechnol 2009, 4(4):265-270.
86. Oh B.R., Sasaki M., Perinchery G., et al. Frequent genotype changes at -308, and 488 regions of the tumor necrosis factor-alpha (TNF-alpha) gene in patients with prostate cancer. J Urol 2000, 163(5):1584-1587.
87. Rood M.J., van Krugten M.V., Zanelli E., et al. TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus. Arthritis Rheum 2000, 43(1):129-134.
88. Boin F., Zanardini R., Pioli R., et al. Association between -G308A tumor necrosis factor alpha gene polymorphism and schizophrenia. Mol Psychiatry 2001, 6(1):79-82.
89. Berrettini W.H., Persico A.M. Dopamine D2 receptor gene polymorphisms and vulnerability to substance abuse in African Americans. Biol Psychiatry 1996, 40(2):144-147.
90. Alvarez V., Mata I.F., Gonzalez P., et al. Association between the TNF-alpha -308 A/G polymorphism and the onset age of Alzheimer disease. Am J Med Genet 2002, 114:574-577.
91. Braun N., Michel U., Ernst B.P., et al. Gene polymorphism at position -308 of the tumor-necrosis-factor-alpha (TNF-alpha) in multiple sclerosis and its influence on the regulation of TNF-alpha production. Neurosci Lett 1996, 215(2):75-78.
92. Li Kam Wa T.C., Mansur A.H., Britton J., et al. Association between -308 tumour necrosis factor promoter polymorphism and bronchial hyperreactivity in asthma. Clin Exp Allergy 1999, 29(9):1204-1208.
93. Kalish R.B., Vardhana S., Gupta M., et al. Polymorphisms in the tumor necrosis factor-alpha gene at position -308 and the inducible 70 kd heat shock protein gene at position +1267 in multifetal pregnancies and preterm premature rupture of fetal membranes. Am J Obstet Gynecol 2004, 191(4):1368-1374.
94. Opdal S.H. IL-10 gene polymorphisms in infectious disease and SIDS. FEMS Immunol Med Microbiol 2004, 42(1):48-52.
95. Freeman B.D., Kennedy C.R., Coopersmith C.M., et al. Genetic research and testing in critical care: surrogates' perspective. Crit Care Med 2006, 34(4):986-994.